Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

RNA Regulation in Medium Spiny Neurons of the Striatum in Parkinson's Disease

Award Number: K08NS144598
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 08/01/2025
PERIOD OF PERFORMANCE END DATE: 07/31/2030

Group Awards By:

View Award Description

RNA Regulation in Medium Spiny Neurons of the Striatum in Parkinson's Disease - PROJECT SUMMARY/ABSTRACT Research: Parkinson's disease is characterized by degeneration of dopaminergic neurons in the substantia nigra, leading to reduced dopaminergic input to the striatum and subsequent motor and cognitive deficits. While the loss of presynaptic dopamine input initiates striatal dysfunction, mere replacement of dopamine is insufficient to effectively treat the disease over time. This gap in knowledge has spurred interest in understanding the molecular dysfunction within the postsynaptic neurons of the striatum. D1 and D2 neurons, named for their predominant expression of dopamine receptors D1 and D2, are the principal postsynaptic neurons of the striatum. They exhibit distinct downstream signaling mechanisms in opposing pathways that together influence striatal function. The overall objective of this project is to identify the molecular mechanisms underlying striatal dysfunction in Parkinson’s disease by investigating aberrant glutamate and dopamine receptor signaling separately in D1 and D2 postsynaptic neurons. This study focuses on the cell-type specific role of the neuronal RNA-binding protein ELAVL3, whose levels are altered in Parkinson’s disease. ELAVL3 is a known modulator of alternative splicing of mRNAs encoding proteins critical for glutamate and dopamine receptor signaling in the mouse striatum. The central hypothesis is that altered RNA-binding function of ELAVL3 leads to aberrant splicing in D1 and D2 neurons, ultimately disrupting striatal function in Parkinson’s disease. The applicant will test this hypothesis by leveraging technical breakthroughs in her mentors’ laboratories that enable the isolation of D1 and D2 neurons from postmortem brains to study RNA regulatory mechanisms within specific cell types. The project has two specific aims: 1) To identify the role of alternative splicing in aberrant glutamate and dopamine receptor signaling in Parkinson’s disease 2) To determine the role of ELAVL3 on alternative splicing and downstream signaling in D1 and D2 neurons in Parkinson’s disease. This research is expected to shed light on the molecular mechanisms involved in striatal dysfunction in Parkinson’s disease, potentially leading to the development of novel therapeutic approaches. Candidate: The applicant Dr. Krithi Irmady is a movement-disorders neurologist and Instructor at the Rockefeller University, who aims to become an independent, tenure-track physician- scientist investigating RNA biology in Parkinson’s disease. Dr. Irmady has outlined a five-year period of mentored training where she will develop skills in fluorescence activated nuclear sorting, cell-type specific profiling of RNA binding protein targets, and experimental manipulation of splicing in neuronal culture systems to study RNA dysregulation in Parkinson’s disease. Environment: The proposed research will be done in Rockefeller University, one of the world’s leading biomedical research universities. The University exposes trainees to an exceptionally robust academic research environment with a strong commitment and track record of successfully supporting junior faculty who are seeking careers as independent investigators.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $220,260 )
2026	2026	ROCKEFELLER UNIVERSITY	1230 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	8/4/2026	NON-COMPETING CONTINUATION	$220,260
														Subtotal = $220,260

Issue Date FY: 2025 ( Subtotal = $220,260 )
2025	2025	ROCKEFELLER UNIVERSITY	1230 YORK AVE	NEW YORK	NY	10065	NEW YORK	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	7/30/2025	NEW	$220,260
														Subtotal = $220,260

Grand Total All Awards = $440,520

Top

All Categories

About

Search

Reports

Data Submission

Award Information

RNA Regulation in Medium Spiny Neurons of the Striatum in Parkinson's Disease

Award Number: K08NS144598

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 08/01/2025

PERIOD OF PERFORMANCE END DATE: 07/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer